Sellas Life Sciences Competitors and Similar CompaniesClear all
Sellas Life Sciences's competitors and similar companies include Marker Therapeutics, Amolyt Pharma, Tosk and Bionomics.
 Sellas Life Sciences SELLAS Life Sciences is a clinical biopharmaceutical company focused on the development of cancer immunotherapies. |  Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. |  Tosk Tosk is a biopharmaceutical company that provides drug development solutions for cancer treatment. |  Bionomics Bionomics is a clinical-stage biopharmaceutical company developing ion channels targeting drug candidates designed for patients suffering from central nervous system (CNS) disorders. | |
Founding Date | Founding Date 2006 | Founding Date 2018 | Founding Date 2015 | Founding Date 2008 | Founding Date 1996 |
Type | Type Public | Type Public | Type Subsidiary | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations New York, US HQ New York, US | Locations Houston, US HQ | Locations Écully, FR HQ Cambridge, US | Locations Mountain View, US HQ Sunnyvale, US | Locations Eastwood, AU HQ |
Employees | Employees 538% decrease | Employees 888% decrease | Employees 373% decrease | Employees 109% decrease | Employees 7 |
Valuation ($) | Valuation ($) 79.1 m | Valuation ($) 36.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $264k (FY, 2022) |
Net income | Net income ($26.9m) (FY, 2025) | Net income ($12.2m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($21.8m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 93.1m | Total funding raised $ 8.6m | Total funding raised $ 10.4m |
For sources of this data, please see the company profile
View Company Profiles
Marker Therapeutics
HQ
Houston, US
Employees
8
Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.
View companyAmolyt Pharma
HQ
Écully, FR
Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View companyTosk
HQ
Mountain View, US
Employees
10↓ 9% decrease
Tosk is a biopharmaceutical company that provides drug development solutions for cancer treatment.
View companyBionomics
HQ
Eastwood, AU
Bionomics is a clinical-stage biopharmaceutical company developing ion channels targeting drug candidates designed for patients suffering from central nervous system (CNS) disorders.
View company